Erratum: Sleep apnoea and visceral adiposity in middle-aged male and female subjects (European Respiratory Journal (2013) 41 (601-609) DOI: 10.1183/09031936.00183411);Sleep apnoea and visceral adiposity in middle-aged male and female subjects

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 601-609

  Kritikou, Ilia ^a   Basta, Maria ^a   Tappouni, Rafel ^a   Pejovic, Slobodanha ^a   Fernandez Mendoza, Julio ^a   Nazir, Racha ^a   Shaffer, Michelle L ^a   Liao, Duanping ^a   Bixler, Edward O ^a   Chrousos, George P ^b   Vgontzas, Alexandros N ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Abdominal fat; Continuous positive airway pressure; Post menopausal; Sleepdisordered breathing; Visceral adiposity

Indexed keywords

PLACEBO;

ABDOMINAL OBESITY; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SLEEP STAGE; SUBCUTANEOUS FAT; THERAPY EFFECT; TREATMENT DURATION; VENTILATORS AND CPAP EQUIPMENT; WEIGHT REDUCTION;

EID: 84875264700     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.51834-2011     Document Type: Erratum

References (36)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
2. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleepdisordered breathing in women: Effects of gender. Am J Respir Crit Care Med 2001; 163: 608-613.
3. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Chrousos GP sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000; 82: 1313-1316.
4. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008; 38: 585-595.
5. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241: 11-18.
6. Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005; 33: 100-104.
7. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal fat visceral fat and serum leptin levels in patients with OSAS following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706-712.
8. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007; 9: 679-687.
9. Munzer T, Hegglin A, Stannek T, et al. Effects of long-term continuous positive airway pressure on body composition and IGF1. Eur J Endocrinol 2010; 162: 695-704.
10. Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev 2008; 12: 481-496.
11. Phillips BA, Collop NA, Drake C, et al. Sleep disorders and medical conditions in women. Proceedings of the Women & Sleep Workshop, National Sleep Foundation, Washington, DC, March 5-6, 2007. J Womens Health (Larchmt) 2008; 17: 1191-1199.
12. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40: 1387-1395.
13. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington DC, US Government Printing Office, NIMH Publication 204, 1968.
14. Yajima Y, Narui T, Ishii M, et al. Computed tomography in the diagnosis of fatty liver: Total lipid content and computed tomography number. Tohoku J Exp Med 1982; 136: 337-342.
15. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994; 23: 991-999.
16. Franklin RM, Ploutz-Snyder L, Kanaley JA. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 2009; 58: 311-315.
17. Enzi G, Gasparo M, Biondetti PR, et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986; 44: 739-746.
18. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: Role of insulin resistance. J Clin Endocrinol Metab 2001; 86: 517-520.
19. Tasali E, Van Cauter E, Hoffman L, et al. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 3878-3884.
20. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 2002; 967: 363-378.
21. Kursawe R, Eszlinger M, Narayan D, et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: Association with insulin resistance and hepatic steatosis. Diabetes 2010; 59: 2288-2296.
22. Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42: 1175-1183.
23. Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298: 309-316.
24. Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
25. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
26. Millman RP, Carlisle CC, McGarvey ST, et al. Body fat distribution and sleep apnea severity in women. Chest 1995; 107: 362-366.
27. Martinez-Rivera C, Abad J, Fiz JA, et al. Usefulness of truncal obesity indices as predictive factors for obstructive sleep apnea syndrome. Obesity (Silver Spring) 2008; 16: 113-118.
28. Soriano-Co M, Vanhecke TE, Franklin BA, et al. Increased central adiposity in morbidly obese patients with obstructive sleep apnea. Intern Med J 2011; 41: 560-566.
29. Redenius R, Murphy C, O'Neill E, et al. Does CPAP lead to change in BMI? J Clin Sleep Med 2008; 4: 205-209.
30. Quan SF. Proceedings of the National Sleep Foundation meeting. Washington DC, National Sleep Foundation, 2006.
31. Vgontzas AN. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Arch Physiol Biochem 2008; 114: 211-223.
32. Johansson K, Neovius M, Lagerros YT, et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: A randomised controlled trial. BMJ 2009; 339: B4609.
33. Romero-Corral A, Caples SM, Lopez-Jimenez F, et al. Interactions between obesity and obstructive sleep apnea: Implications for treatment. Chest 2010; 137: 711-719.
34. Foster GD, Borradaile KE, Sanders MH, et al. Sleep AHEAD Research Group of Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study. Arch Intern Med 2009; 169: 1619-1626.
35. Phillips CL, Yee BJ, Trenell MI, et al. Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. J Clin Sleep Med 2009; 5: 416-421.
36. Totsikas C, Rohm J, Kantartzis K, et al. Cardiorespiratory fitness determines the reduction in blood pressure and insulin resistance during lifestyle intervention. J Hypertens 2011; 29: 1220-1227.